Neoplasm Transplantation
Liver Transplantation
Transplantation, Homologous
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Transplantation, Autologous
Lung Transplantation
Stem Cell Transplantation
The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.
Transplantation Conditioning
Organ Transplantation
Graft Survival
Graft Rejection
Islets of Langerhans Transplantation
Tissue Donors
Transplantation
Transplantation Immunology
Cell Transplantation
Transplantation Chimera
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Treatment Outcome
Transplantation, Isogeneic
Graft vs Host Disease
Transplantation, Heterotopic
Cord Blood Stem Cell Transplantation
Heart-Lung Transplantation
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Neoplasms
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Hematologic Neoplasms
Tissue and Organ Procurement
The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.
Transplantation Tolerance
Peripheral Blood Stem Cell Transplantation
Liver Failure
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Immunosuppression
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
Histocompatibility Testing
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
Fetal Tissue Transplantation
Postoperative Complications
Skin Transplantation
Neoplasms, Cystic, Mucinous, and Serous
Follow-Up Studies
Mesenchymal Stem Cell Transplantation
Corneal Transplantation
Histocompatibility
Survival Rate
Survival Analysis
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Tacrolimus
Tissue Transplantation
Whole-Body Irradiation
Cyclosporine
Neoplasms, Second Primary
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Brain Tissue Transplantation
Neoplasms, Multiple Primary
Facial Transplantation
Donor Selection
The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients.
Organ Preservation
Immunohistochemistry
Prognosis
Combined Modality Therapy
Busulfan
An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.
Risk Factors
Transplants
HLA Antigens
Kidney Failure, Chronic
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Myeloproliferative Disorders
Bronchiolitis Obliterans
Fatal Outcome
Biopsy
Remission Induction
Antilymphocyte Serum
Adenocarcinoma, Mucinous
Hand Transplantation
Anemia, Aplastic
Liver
Cyclophosphamide
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Blood Group Incompatibility
An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).
Cytomegalovirus Infections
Mycophenolic Acid
An antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1301)
Myeloablative Agonists
Disease-Free Survival
Lymphoma, Non-Hodgkin
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Tissue and Organ Harvesting
Neoplasms, Experimental
Multiple Myeloma
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
Prospective Studies
Incidence
Neoplasms, Plasma Cell
End Stage Liver Disease
Cell Differentiation
Leukemia, Myeloid, Acute
Patient Selection
T-Lymphocytes
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Cystadenoma
Neoplasms, Connective and Soft Tissue
Brain Death
A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state (e.g., sedative overdose, hypothermia, etc.) are excluded prior to making the determination of brain death. (From Adams et al., Principles of Neurology, 6th ed, pp348-9)
Actuarial Analysis
The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.
Ovarian Neoplasms
Myelodysplastic Syndromes
Melphalan
Liver Failure, Acute
A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
Neoplasm Recurrence, Local
Bone Marrow Cells
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Liver Cirrhosis
Antineoplastic Combined Chemotherapy Protocols
Cystadenoma, Mucinous
Neoplasm Staging
Lymphoproliferative Disorders
Gastrointestinal Neoplasms
Disease Models, Animal
Primary Graft Dysfunction
Antigens, Neoplasm
Chimerism
ABO Blood-Group System
The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.
Antigens, CD34
Stem Cells
Neoplasms, Radiation-Induced
Graft vs Leukemia Effect
Testicular Neoplasms
Hodgkin Disease
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Delayed Graft Function
Infection
Carcinoma, Pancreatic Ductal
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Lymphocyte Transfusion
Neoplasms, Muscle Tissue
Lymphocyte Depletion
Hematopoietic Stem Cell Mobilization
Biliary Atresia
Bone Marrow
The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
Neoplasms, Vascular Tissue
Neoplasm Proteins
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Neoplasms, Glandular and Epithelial
Cold Ischemia
The chilling of a tissue or organ during decreased BLOOD perfusion or in the absence of blood supply. Cold ischemia time during ORGAN TRANSPLANTATION begins when the organ is cooled with a cold perfusion solution after ORGAN PROCUREMENT surgery, and ends after the tissue reaches physiological temperature during implantation procedures.
Tomography, X-Ray Computed
Hematopoiesis
Kaplan-Meier Estimate
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Hepatic Veno-Occlusive Disease
Anastomosis, Surgical
Isoantibodies
Cohort Studies
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Adenocarcinoma, Papillary
Flow Cytometry
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
Graft vs Tumor Effect
Carcinoma, Papillary
Multivariate Analysis
Kidney
Postoperative Care
Cells, Cultured
Soft Tissue Neoplasms
Vidarabine
A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.
Risk Assessment
Cystadenocarcinoma, Mucinous
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
Age Factors
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Leukemia, Myeloid
Vascular Neoplasms
Models, Animal
Salvage Therapy
Azathioprine
Classification of human colorectal adenocarcinoma cell lines. (1/10282)
Eleven human colorectal adenocarcinoma cell lines established in this laboratory were classified into three groups based on morphological features (light and electron microscopy), modal chromosome number, and ability to synthesize carcinoembryonic antigen (CEA). Group 1 cell lines contained both dedifferentiated and differentiating cells growing in tight clusters or islands of epithelium-like cells; their modal chromosome number was about 47, and they synthesized small to moderate amounts of CEA. Group 2 cell lines were more dedifferentiated, were hyperdiploid, and synthesized small amounts of CEA. Group 3 cell lines were morphologically similar to those of Group 1 by light microscopy. They differed ultrastructurally by containing microvesicular bodies; the modal chromosome number varied from hyperdiploid to hypertriploid or they had bimodal populations of hypodiploid and hypertriploid cells, and they synthesized relatively large amounts of CEA. No correlation could be found between Broder's grade or Duke's classification of the original tumor and modal chromosome number or ability to synthesize CEA. These findings support Nowell's hypothesis that the stem line is different for each solid tumor, which makes it difficult to relate chromosomal changes to the initiation of the neoplastic state. (+info)Long-term transplantability and morphological stability of three experimentally induced urinary bladder carcinomas in rats. (2/10282)
Three transitional cell carcinomas induced in Fischer 344 rats by a methylcholanthrene pellet or a foreign body inserted locally into the bladder have been serially transplanted in the syngeneic strain for up to 6.5 years. There have been no changes in the individual morphological characteristics of the tumors during this time. Cells cultured in vitro for varying numbers of passages reproduce regularly the morphology of each tumor when they are injected back into the animals and results from a microcytotoxicity assay for cellular immunity indicate that they retain a common, bladder tumor-specific antigen. These tumors are useful for research in turmo biology and are offered to other scientists seeking transplantable carcinomas for experimentation. (+info)Natural history of papillary lesions of the urinary bladder in schistosomiasis. (3/10282)
Variable epithelial hyperplasia was observed in urinary bladder of nine capuchin monkeys (Cebus apella) when examined at cystotomy 94 to 164 weeks after infection with Schistosoma haematobium. These hosts were followed for 24 to 136 weeks postcystotomy to determine the status of bladder lesions in relation to duration of infection and to ascertain whether lesion samples removed at cystotomy reestablished themselves in autologous and heterologous transfers. There was involution of urothelial hyperplasia in eight of nine animals and no evidence for establishment of transplanted bladder lesions. (+info)Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL). (4/10282)
Fas ligand is a type II transmembrane protein which can induce apoptosis in Fas-expressing cells. Recent reports indicate that expression of FasL in transplanted cells may cause graft rejection and, on the other hand, tumor cells may lose their tumorigenicity when they are engineered to express FasL. These effects could be related to recruitment of neutrophils by FasL with activation of their cytotoxic machinery. In this study we investigated the antitumor effect of allogenic fibroblasts engineered to express FasL. Fibroblasts engineered to express FasL (PA317/FasL) did not exert toxic effects on transformed liver cell line (BNL) or colon cancer cell line (CT26) in vitro, but they could abrogate their tumorigenicity in vivo. Histological examination of the site of implantation of BNL cells mixed with PA317/FasL revealed massive infiltration of polymorphonuclear neutrophils and mononuclear cells. A specific immune protective effect was observed in animals primed with a mixture of BNL or CT26 and PA317/FasL cells. Rechallenge with tumor cells 14 or 100 days after priming resulted in protection of 100 or 50% of animals, respectively. This protective effect was due to CD8+ cells since depletion of CD8+ led to tumor formation. In addition, treatment of pre-established BNL tumors with a subcutaneous injection of BNL and PA317/FasL cell mixture at a distant site caused significant inhibition of tumor growth. These data demonstrate that allogenic cells engineered with FasL are able to abolish tumor growth and induce specific protective immunity when they are mixed with neoplastic cells. (+info)Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. (5/10282)
[18F]Fluorodeoxyglucose ([18F]FDG), a glucose analogue, has been widely used for tumor imaging. To investigate the mechanisms related to [18F]FDG uptake by tumors, an experiment involving nude mice was performed. METHODS: Human colon cancer cell lines SNU-C2A, SNU-C4 and SNU-C5 were transplanted to nude mice. Using immunohistochemical staining and Western blot, the expression of glucose transporter (Glut) isoforms (Glut-1 through -5) in xenografted tumors was analyzed. For the analysis of messenger ribonucleic acid (mRNA) expression, reverse-transcription polymerase chain reaction and Northern blot were used and the enzyme activity of hexokinase in cancer tissues was measured by continuous spectrophotometric rate determination. RESULTS: [18F]FDG uptake in SNU-C4 and SNU-C5 cells was higher than in normal colon cells. Among these cells and xenografted tumors, SNU-C5 showed the highest level of [18F]FDG uptake, followed by SNU-C4 and SNU-C2A. An immunostaining experiment showed intense staining of Glut-1 in SNU-C5 tumors but somewhat faint staining in SNU-C4. SNU-C5 tumors also showed positive staining with Glut-3, although this was not the case with SNU-C2A and SNU-C4. Western blot analysis showed the expression of Glut-1 and Glut-3 in all tumors. Experiments involving Northern blot analysis and reverse-transcription polymerase chain reaction confirmed the overexpression of Glut-1 mRNA in all tumors, with the highest level in SNU-C5. The level of Glut-3 mRNA was also elevated in SNU-C5 tumors but not in SNU-C2A and SNU-C4. The enzyme activity of hexokinase did not vary among different tumors. CONCLUSION: Gluts, especially Glut-1, are responsible for [18F]FDG uptake in a nude mouse model of colon cancer rather than hexokinase activity. Increased numbers of glucose transporters at the plasma membrane of cancer cells is attributed to an increased level of transcripts of glucose transporter genes and may be a cause of increased [18F]FDG uptake, at least in colon cancer tumors. (+info)99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies. (6/10282)
Vasoactive intestinal peptide (VIP) is a naturally occurring 28-amino acid peptide with a wide range of biological activities. Recent reports suggest that VIP receptors are expressed on a variety of malignant tumor cells and that the receptor density is higher than for somatostatin. Our aims were to label VIP with 99mTc--a generator-produced, inexpensive radionuclide that possesses ideal characteristics for scintigraphic imaging--and to evaluate 99mTc-VIP for bioactivity and its ability to detect experimental tumors. METHODS: VIP28 was modified at the carboxy terminus by the addition of four amino acids that provided an N4 configuration for a strong chelation of 99mTc. To eliminate steric hindrance, 4-aminobutyric acid (Aba) was used as a spacer. VIP28 was labeled with 1251, which served as a control. Biological activity of the modified VIP28 agonist (TP3654) was examined in vitro using a cell-binding assay and an opossum internal anal sphincter (IAS) smooth muscle relaxivity assay. Tissue distribution studies were performed at 4 and 24 h after injection, and receptor-blocking assays were also performed in nude mice bearing human colorectal cancer LS174T. Blood clearance was examined in normal Sprague-Dawley rats. RESULTS: The yield of 99mTc-TP3654 was quantitative, and the yields of 125I-VIP and 1251-TP3654 were >90%. All in vitro data strongly suggested that the biological activity of 99mTc-TP3654 agonist was equivalent to that of VIP28. As the time after injection increased, radioactivity in all tissues decreased, except in the receptor-enriched tumor (P = 0.84) and in the lungs (P = 0.78). The tumor uptake (0.23 percentage injected dose per gram of tissue [%ID/g]) was several-fold higher than 125I-VIP (0.06 %ID/g) at 24 h after injection in the similar system. In mice treated with unlabeled VIP or TP3654, the uptake of 99mTc-TP3654 decreased in all VIP receptor-rich tissues except the kidneys. The blood clearance was biphasic; the alpha half-time was 5 min and the beta half-time was approximately 120 min. CONCLUSION: VIP28 was modified and successfully labeled with 99mTc. The results of all in vitro examinations indicated that the biological activity of TP3654 was equivalent to that of native VIP28 and tumor binding was receptor specific. (+info)In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats. (7/10282)
Isolated perfusion of the extremities with high-dose tumour necrosis factor alpha (TNF-alpha) plus melphalan leads to dramatic tumour response in patients with irresectable soft tissue sarcoma or multiple melanoma in transit metastases. We developed in vivo isolated organ perfusion models to determine whether similar tumour responses in solid organ tumours can be obtained with this regimen. Here, we describe the technique of isolated kidney perfusion. We studied the feasibility of a perfusion with TNF-alpha and assessed its anti-tumour effects in tumour models differing in tumour vasculature. The maximal tolerated dose (MTD) proved to be only 1 microg TNF-alpha. Higher doses appeared to induce renal failure and a secondary cytokine release with fatal respiratory and septic shock-like symptoms. In vitro, the combination of TNF-alpha and melphalan did not result in a synergistic growth-inhibiting effect on CC 531 colon adenocarcinoma cells, whereas an additive effect was observed on osteosarcoma ROS-1 cells. In vivo isolated kidney perfusion, with TNF-alpha alone or in combination with melphalan, did not result in a significant anti-tumour response in either tumour model in a subrenal capsule assay. We conclude that, because of the susceptibility of the kidney to perfusion with TNF-alpha, the minimal threshold concentration of TNF-alpha to exert its anti-tumour effects was not reached. The applicability of TNF-alpha in isolated kidney perfusion for human tumours seems, therefore, questionable. (+info)Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. (8/10282)
Interleukin 6 (IL-6) is a multifunctional cytokine. Recent reports suggest that circulating IL-6 secreted from tumour cells plays an important role in cancer-induced cachexia. Medroxyprogesterone acetate (MPA) has been used as an endocrine therapeutic agent for patients with breast cancer. It has been suggested that MPA decreases serum IL-6 levels and preserves the bodyweight of patients with advanced breast cancer. However, the mechanisms of action responsible for the anticachectic effect of MPA have not been elucidated. Therefore, the effects of MPA on IL-6 secretion were studied both in vitro and in vivo using a human breast cancer cell line, KPL-4, which secretes IL-6 into medium and induces cachexia when injected into female nude mice. MPA (10-1000 nM) dose-dependently decreased basal IL-6 secretion into medium, and also suppressed tumour necrosis factor (TNF-alpha)-induced IL-6 secretion. Both basal and TNF-alpha-induced IL-6 mRNA levels were dose-dependently lowered by MPA. Moreover, intramuscular injections of MPA (100 mg kg(-1) twice a week) into nude mice bearing KPL-4 transplanted tumours significantly decreased serum IL-6 levels without affecting tumour growth and preserved the bodyweight of recipient mice. These findings suggest that suppression of IL-6 secretion from tumour cells, at least in part, causes the anticachectic effect of MPA. (+info)
Human brain tumor transplantation into nude mice. by W R. Shapiro, G A. Basler et al.
1</sup>H-NMR relaxation times and water compartmentalization in experimental tumor models...
Studies on the Genetic and Antigenic Basis of Tumour Transplantation. Linkage between a Histocompatibility Gene and Fused in...
Blood test could predict who will benefit from immunotherapy, researchers find | Mirage News
New nano-therapy finds and kills deadly tumors - The Exception Magazine
Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: Correlation of...
Plus it
AID 710427 - Binding affinity to TLR2 in human SU.86.86 cells xenografted in Harlan athymic nude mouse tumor assessed as...
Successful heterotransplantation of l1210 mouse leukosis into un- trea by C A. Apffel and J H. Peters
GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability | Cancer...
Pathological aspects - Immune Response - Barnard Health Care
Should All Potentially Lethal Tumors Be Sequenced? - The Lundberg Institute
Plus it
iwCLL 2017| Anti-CD19 CAR-T cell therapy with defined T-cell subsets for ibrutinib-refractory CLL
Cancer Research
Plus it
Neoplasm Transplantation | The Chopra Library
546238A | FAG Bearing | reliable bearing online
Definition for nude mouse
Decreased macrophage‐mediated cytotoxicity in mammary‐tumor‐bearing mice is related to alteration of nitric‐oxide production...
Plus it
Detection of Simian Virus 40 T-Antigen-related Antigens by a 125I-Protein A-binding Assay and by Immunofluorescence Microscopy...
Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays...
Plus it
Plus it
Abdominal-wall tumor implantation after laparoscopy for malignant conditions<...
Magnetic resonance imaging of nude mice with heterotransplanted high-grade squamous cell carcinomas: use of a low-loaded,...
An Animal Model for Human Tumor Xenografts | SpringerLink
SNU-C2B | Creative Bioarray
Exploring the similarities between neointimal formation after vascular injury and tumour growth at University of Bristol on...
Plus it
Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer - Full Text View - ClinicalTrials...
Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer - Tabular View - ClinicalTrials.gov
Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors - Fingerprint...
Meta-tyrosine: A powerful anti-metastatic factor with undetectable toxic-side effects
Tumor Models in Cancer Research | Beverly A. Teicher | Springer
CIL:42163, Homo sapiens, epithelial cell. CIL. Dataset
Annibale Carracci Fine Art Open Edition Gicl e:A Male Nude Seated with His Back Turned - Annibale Carracci
Sachedev Sidhu
TIMKEN [ 280RJ92 ] Bearing - bearing sale
23030-E1A-K-M H3030 | FAG Bearing | bearing leader
KOYO 51280 bearing - bearing products PYAN bearing - pyantakinderkleding.nl
NJ318R KOYO Bearing | NJ318R Bearing - bearingforworld.c...
B-1 cells and concomitant immunity in Ehrlich tumour progression
Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo - SAHMRI
Athymic nude mouse | definition of Athymic nude mouse by Medical dictionary
A heterotopic model for tumor-associated (lymph)angiogenesis in the murine cornea - feasibility of intrastromal tumor cell...
Comparison of L bleomycin prepared by two methods: Stability and pharmacokinetics in tumor bearing mice<...
Protective immunity induced by B7.1+IL-12 transfected tumor cells is abrogated by tumor growth in an immune privileged site<...
Quantitation of anti-tumor cell-mediated immunity by a lymphokine-Dependent reaction using small volumes of blood - UQ eSpace
SNU-C2B ATCC ® CCL-250™ Homo sapiens colorectal carcinoma
Testosterone inhibits the growth of prostate cancer xenografts in nude mice | BMC Cancer | Full Text
JCI -
Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer
JCI -
Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer
IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral...
Dovitinib | her2 signaling
June | 2014 | Atpase Signaling
Subarachnoid Hemorrhage and Tumor Implants from Spinal Sarcoma in an Infant | Neurology
Systems Biology of Tumor Dormancy
Antibody producing cells in transplantation immunity
Plus it
Murine Models of Cancer
PDT in tumor-bearing mice. (a) 4T1 cells were injected | Open-i
60/1060 price - NTN Bearing brand bearing specialist top 5 bearing - alpenkids.nl
What is a Xenograft? (with pictures)
NU酷-NUSKIN如新产品图-美容仪视频-护肤品图片-NUSKIN如新中国官网
居家智能美容保養鏈」 彙整 - WinNews-威傳媒
Extramedullary hematopoiesis
EMH in the lymph nodes is usually associated with underlying hematopoietic neoplasms. Myeloproliferative neoplasms (MPNs) tend ... This includes transplantation, hepatic tumors, hepatic disorders, or sepsis. Hepatoblastoma, adenomas and hepatocellular ... para-nasal sinuses and numerous types of benign/malignant neoplasms. The most common sites of EMH associated with neoplastic ... "Pulmonary extramedullary hematopoiesis in patients with myelofibrosis undergoing allogeneic stem cell transplantation". ...
Library of Congress Classification:Class R -- Medicine
Reparative surgery 120.6-129.8.............................Transplantation of organs, tissues, etc. 130 ... Neoplasms. Tumors. Oncology 680-688...................................Diseases of the locomotor system (Surgical treatment) 701 ... Neoplasms. Tumors. Oncology Including cancer and carcinogens 306-320.5................................Tuberculosis 321-571 ...
Neoplasm
"The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation". N. Engl. J. Med. 332 (1 ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... The term neoplasm is a synonym of tumor. Neoplasia denotes the process of the formation of neoplasms/tumors, and the process is ... The process that occurs to form or produce a neoplasm is called neoplasia. The growth of a neoplasm is uncoordinated with that ...
Clonal hematopoiesis
Hematopoietic stem cell Hematopoietic stem cell transplantation Hematology Myelodysplastic syndrome Myeloproliferative neoplasm ... It has been shown that patients with CHIP who receive autologous stem cell transplantation (ASCT) as part of their treatment ... The poorer prognosis for these patients is due to both an increase in subsequent therapy-related myeloid neoplasms and ... "Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma". Journal of ...
Draco Rosa
He followed several alternative treatments, such as high vitamin C doses or neoplasm treatment at the Burzynski Clinic in ... Finally, he underwent conventional treatments of chemotherapy and bone marrow transplantation. He was under quarantine in his ...
Shahinaz Gadalla
Gadalla's work focuses on severe aplastic anemia and myeloid neoplasms with a goal of identifying biomarkers that can guide ... She also researches molecular predictors of outcomes after hematopoietic cell transplantation. ... is a physician-scientist and cancer epidemiologist who researches cancer biomarkers and hematopoietic stem cell transplantation ...
Clonal hypereosinophilia
... lymphoid neoplasms, or features of both types of neoplasms. Most commonly, the present with features of myeloid neoplasms with ... This patient achieved a complete hematological response and was then given a hematopoietic stem cell transplantation. The ... Like the latter neoplasm, hematologic neoplasms cause by ETV6-JAK2 and BCR-JAK2 are aggressive and progress rapidly. Too few ... A classic example of such a disease is chronic myelogenous leukemia, a neoplasm commonly caused by a mutation that creates the ...
Bob Turner (Canadian politician)
... myeloproliferative neoplasms, mast cell diseases and stem cell transplantation. In the past, Turner was the medical director of ...
Myeloproliferative neoplasm
Hematopoietic stem cell transplantation can be a curative treatment for a small group of patients, however MPN treatment is ... In MPNs, the neoplasm (abnormal growth) starts out as benign and can later become malignant. As of 2016, the World Health ... Myeloproliferative neoplasms (MPNs) are a group of rare blood cancers in which excess red blood cells, white blood cells or ... Myelo refers to the bone marrow, proliferative describes the rapid growth of blood cells and neoplasm describes that growth as ...
Myelodysplastic syndrome
Stem-cell transplantation offers possible cure, with survival rates of 50% at 3 years, although older patients do poorly. ... Fever, weight loss and splenomegaly should point to a myelodysplastic/myeloproliferative neoplasm (MDS/MPN) rather than pure ... The success of bone marrow transplantation has been found to correlate with severity of MDS as determined by the IPSS score, ... HLA-matched allogeneic stem cell transplantation, particularly in younger (i.e. less than 40 years of age) and more severely ...
FIP1L1
Vega F, Medeiros LJ, Bueso-Ramos CE, Arboleda P, Miranda RN (2015). "Hematolymphoid neoplasms associated with rearrangements of ... the aggressive chemotherapy and/or bone marrow transplantation used to treat aggressive leukemia may be required. While the ... Reiter A, Gotlib J (2017). "Myeloid neoplasms with eosinophilia". Blood. 129 (6): 704-714. doi:10.1182/blood-2016-10-695973. ... a type of myeloproliferative neoplasm/myeloblastic leukemia not distinguished by eosinophilia; or c) T-lymphoblastic leukemia/ ...
Risk factors for tuberculosis
... renal and cardiac transplantation, carcinoma of the head or neck, and other neoplasms (e.g., lung cancer, lymphoma, and ...
Victor Gomoiu
Topics included meningoencephalitis, cerebral atrophy, facial nerve paralysis, fibrous tissue neoplasm, lipoma, the anatomy of ... the endothelium, corneal transplantation, skin grafting, dental implants, hysterectomy, various types of cysts and "rare tumors ...
Myeloperoxidase deficiency
Secondary MPO deficiency, on the other hand, occurs in various clinical situations as a result of hematological neoplasm, ... disseminated cancers, some drugs, iron deficiency, lead intoxication, thrombotic disease, renal transplantation, severe ...
Chronic myelomonocytic leukemia
The myeloid neoplasms contain acute and chronic leukemias, myelodysplastic syndromes (MDSs) and myeloproliferative neoplasms ( ... Hematopoietic stem cell transplantation remains the only curative treatment for CMML. However, due to the late age of onset and ... In 2001, the WHO Classification of Myeloid Neoplasms was published, classifying CMML into a new group of diseases, the ... Leukaemias are subdivided into lymphoid and myeloid neoplasms, depending on which bone marrow cells are cancerous. ...
Marcel R.M. van den Brink
"neoplasms"[MH] OR "transplantation"[ALL] OR "graft vs. host disease"[MH] OR "stem cell*"[ALL] OR "t-lymphocytes"[MH]) OR sloan- ... As a physician-scientist, van den Brink studies cancer immunotherapy with a special interest in bone marrow transplantation, T ... "Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation". N Engl J Med. 2020 Feb 27;382(9):822- ... "Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation ...
Sebaceous carcinoma
The incidence of MTS in patients with sebaceous neoplasms as high as 14 to 50%. Besides mutations in mismatch repair genes, Wnt ... there is evidence to suggest that solid organ transplantation may increase the risk of SGc up to 90 times. Others have observed ... SGc accounts for approximately 0.7% of all skin cancers and 0.2 to 4.6% of all malignant cutaneous neoplasms. Notable risk ... MTS is an autosomal dominant cancer syndrome characterized by multiple sebaceous and visceral neoplasms, the most common being ...
Hepatectomy
Most hepatectomies are performed for the treatment of hepatic neoplasms, both benign or malign. Benign neoplasms include ... Partial hepatectomies are also performed to remove a portion of a liver from a living donor for transplantation.[citation ... The most common malignant neoplasms (cancers) of the liver are metastases; those arising from colorectal cancer are among the ... typically cancer centres and transplantation centres).[citation needed] For optimal results, combination treatment with ...
King Fahad Specialist Hospital Dammam
King Fahad Specialist Hospital-Dammam continues to work closely with the Saudi Center for Organ Transplantation (SCOT), the ... chronic myeloproliferative neoplasms, and lymphomas: Hodgkin and non-Hodgkin types Bone marrow failure syndromes: aplastic ... High dose chemotherapy and stem cells rescue [autologous transplantation] for: myeloma, lymphoma, acute myeloid leukemia] ... of KFSH-D was established in 2008 to cover the need for organ transplantations in the Eastern Province and the kingdom. The ...
Intestinal pseudo-obstruction
These include stem-cell transplantation and fecal microbiota transplantation. Cannabis[unreliable source?] has not been studied ... Bowel obstruction: mechanical or functional obstruction of the bowel, most commonly due to adhesions, hernias or neoplasms. ... A potential solution, albeit radical, is intestinal transplantation. This is only appropriate in the case of intestinal failure ... Bond, Geoffrey J.; Reyes, Jorge D. (November 2004). "Intestinal transplantation for total/near-total aganglionosis and ...
Thelma Brumfield Dunn
"Histology of Some Neoplasms and Non-Neo-plastic Lesions Found in Wild Mice Maintained Under Laboratory Conditions". JNCI: ... "Transplantation of Hepatomas in Mice1". JNCI: Journal of the National Cancer Institute. April 1955. doi:10.1093/jnci/15. ... "Histology of Some Neoplasms and Non-Neo-plastic Lesions Found in Wild Mice Maintained Under Laboratory Conditions" (1963), " ... "Transplantation of Hepatomas in Mice" (1955), "Morphology of Mammary Tumors in Mice" (1958), "Studies of the Mammary-Tumor ...
Acute megakaryoblastic leukemia
Further studies may indicate that this recent cancer chemotherapy regimen plus allogenic bone marrow transplantation in cases ... Vardiman JW, Harris NL, Brunning RD (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". ... of cases human stem cell transplantation, the probability of overall 4 year survival rate, probability of 4 year event-free ... allogenic rather than autologous stem cell bone marrow transplantation should be considered in non-DS-AMKL cases that have ...
Harrison's Principles of Internal Medicine
Liver Transplantation Chapter 339: Diseases of the Gallbladder and Bile Ducts Section 4: Disorders of the Pancreas Chapter 340 ... Neoplasms of the Lung Chapter 75: Breast Cancer Chapter 76: Upper Gastrointestinal Tract Cancers Chapter 77: Lower ... Lung Transplantation Part 8: Critical Care Medicine Section 1: Respiratory Critical Care Chapter 293: Approach to the Patient ... Transplantation in the Treatment of Renal Failure Chapter 308: Glomerular Diseases Chapter 309: Polycystic Kidney Disease and ...
Gilles Salles
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma. N Engl J Med. 2017 Sep 28;377(13):1250-1260. ... The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016 19;127(20):2375-90. ...
Laboratory rat
Comparison of Neoplasms in Six Sources of Rats Diamond JM (January 2006). Collapse: How Societies Choose to Fail or Succeed. ... Research applications include transplantation research, induced arthritis and inflammation, experimental allergic encephalitis ... The Lewis rat suffers from several spontaneous pathologies: first, they can suffer from high incidences of neoplasms, with the ... A 1972 study compared neoplasms in Sprague Dawley rats from six different commercial suppliers and found highly significant ...
Arginylglycylaspartic acid
Bone defects or fractures can occur in a number of ways, including trauma, neoplasm, osteoporosis, or congenital disorders. ... the most common treatment for which is allograft cornea transplantation. However, donor corneal grafts are in short supply and ...
ETV6
One patient with ETV6-FLT3-related myeloid/lymphoid neoplasm obtained a short term remission on sunitinib and following relapse ... lymphoblastic leukemia with 2 among 3 family members moving rather quickly from chemotherapy to bone marrow transplantation and ... Reiter A, Gotlib J (February 2017). "Myeloid neoplasms with eosinophilia". Blood. 129 (6): 704-714. doi:10.1182/blood-2016-10- ... myeloproliferative neoplasm (MPN), and acute myeloid leukemia (AML). (The presence of ETV6 gene mutations in myelodysplastic ...
Sertoli cell
Sertoli-Leydig cell tumour is part of the sex cord-stromal tumour group of ovarian neoplasms. These tumors produce both Sertoli ... Upon xenogenic transplantation, Sertoli cells have been shown to regain the ability to proliferate. Recently (2016), ... By treating spontaneously diabetic and obese mice with the transplantation of microencapsulated Sertoli cells in subcutaneous ... "Germ cell transplantation as a potential biotechnological approach to fish reproduction". Fish Physiology and Biochemistry. 39 ...
Murine polyomavirus
STEWART, SE; EDDY, BE; BORGESE, N (June 1958). "Neoplasms in mice inoculated with a tumor agent carried in tissue culture". ... Ramqvist, T; Dalianis, T (August 2009). "Murine polyomavirus tumour specific transplantation antigens and viral persistence in ...
Acute erythroid leukemia
It can also involve bone marrow transplantation. Information on prognosis is limited by the rarity of the condition. Prognosis ... myeloproliferative neoplasms, chemotherapy for other cancers or exposure to toxins were defined as secondary AEL. These cases ... and in patients who had previously received chemotherapy for the treatment of a different neoplasm. Acute erythroid leukemia is ...
Waldenström macroglobulinemia
Allogeneic stem cell transplantation can induce durable remissions for heavily pre-treated patients. As of October 2010, there ... ISBN 978-0-7817-5007-3. Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and ... Autologous bone marrow transplantation is a treatment option. Zanubrutinib is indicated for the treatment of adults with ... Yang L, Wen B, Li H, Yang M, Jin Y, Yang S, Tao J (1999). "Autologous peripheral blood stem cell transplantation for ...
Primary effusion lymphoma
This lymphoma also belongs to a group of lymphoid neoplasms with plasmablastic differentiation that involve malignant ... prior organ transplantation, the decline in immunity that develops with aging, and/or cirrhosis of the liver due to hepatitis B ... List of hematologic conditions Chen BJ, Chuang SS (March 2020). "Lymphoid Neoplasms With Plasmablastic Differentiation: A ... and/or rarely of immune deficiency due to organ transplantation, hepatitis complicated by cirrhosis caused by hepatitis B or C ...
Fibroblast growth factor 23
FGF23 is also overproduced by some types of tumors, such as the benign mesenchymal neoplasm phosphaturic mesenchymal tumor ... Transplantation. 17 (6): 958-61. doi:10.1093/ndt/17.6.958. PMID 12032180. Quarles LD (July 2003). "FGF23, PHEX, and MEPE ...
Chronic lymphocytic leukemia
Autologous stem cell transplantation, using the recipient's own cells, is not curative.: 1458 Younger individuals, if at high ... Hairy cell leukemia is also a neoplasm of B lymphocytes, but the neoplastic cells have a distinct morphology under the ... ISBN 978-0-7817-5007-3. Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and ... CLL is treated by chemotherapy, radiation therapy, biological therapy, or bone marrow transplantation. Symptoms are sometimes ...
Pemigatinib
In the United States it is also indicated for the treatment of relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with ... Eligible participants were either not candidates for or have relapsed after allogeneic hematopoietic stem cell transplantation ... "FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement". U.S. Food and Drug ... for pemigatinib for the treatment of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1 ...
Malignancy
Uses of "malignant" in oncology include: Malignancy, malignant neoplasm and malignant tumor are synonymous with cancer ... Other risk factors include developing post-transplant malignancy which occurs subsequent to solid organ transplantations. ... American Journal of Transplantation. 10 (8): 1889-1896. doi:10.1111/j.1600-6143.2010.03181.x. PMID 20659094. S2CID 40192165. ...
Acute lymphoblastic leukemia
Stem cell transplantation may be used if the disease recurs following standard treatment. Additional treatments such as ... May 2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. ... Moreover, patients undergoing a stem cell transplantation can develop a graft-versus-host disease (GvHD). It was evaluated ... Chemotherapies or stem cell transplantations may require a platelet transfusion to prevent bleeding. ...
IMPDH2
2008). "Association of four DNA polymorphisms with acute rejection after kidney transplantation". Transpl. Int. 21 (9): 879-91 ... been identified as an intracellular target of the natural product sanglifehrin A This gene is up-regulated in some neoplasms, ... The Journal of Heart and Lung Transplantation. 29 (5): 509-516. doi:10.1016/j.healun.2009.11.602. PMID 20061166. Sombogaard F, ... a 2-year follow-up in kidney transplantation". Clin. Pharmacol. Ther. 83 (2): 328-35. doi:10.1038/sj.clpt.6100300. PMID ...
History of cancer chemotherapy
Autologous transplantation continues to be used as a component of therapy for a number of other hematologic malignancies. The ... A study of 93 patients with incurable neoplasms". J Natl Med Assoc. 43 (4): 211-240. PMC 2616951. PMID 14850976. Li, MC; Hertz ... This approach, termed autologous bone marrow transplantation, was initially thought to be of benefit to a wide group of ... However, rigorous studies have failed to confirm this benefit, and autologous transplantation is no longer widely used for ...
Diffuse large B-cell lymphoma associated with chronic inflammation
An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation". The ... who are immune-deficient due to HIV/AIDS or immunosuppressing anti-rejection drug therapy following solid organ transplantation ...
Stem cell marker
March 1997). "Factors predicting morbidity following hematopoietic stem cell transplantation". Bone Marrow Transplantation. 19 ... Misago N, Narisawa Y (September 2006). "Cytokeratin 15 expression in neoplasms with sebaceous differentiation". Journal of ... Bone Marrow Transplantation. 37 (5): 499-502. doi:10.1038/sj.bmt.1705262. PMID 16415895. Suzuki A, Nakauchi H, Taniguchi H ( ... Transplantation. 78 (4): 516-23. doi:10.1097/01.TP.0000128854.20831.6F. PMID 15446309. S2CID 84476256. Valente T, Junyent F, ...
Interventional radiology
Over 100 years later, the only available curative, renal replacement therapy for CKD is kidney transplantation. However, many ... such as osteoporosis or underlying neoplasm. Analogous to vertebroplasty, the purpose of sacroplasty is to provide ...
Clonally transmissible cancer
Before transplantation, the organ donor was deemed to have no signs of cancer upon medical examination. Later, the organ ... Frierman EM, Andrews JD (February 1976). "Occurrence of hematopoietic neoplasms in Virginia oysters (Crassostrea virginica)". ... In humans, a significant fraction of Kaposi's sarcoma occurring after transplantation may be due to tumorous outgrowth of donor ... American Journal of Transplantation. 18 (7): 1810-1814. doi:10.1111/ajt.14766. PMID 29633548. Muehlenbachs A, Bhatnagar J, ...
Cyclophosphamide
Fuchs EJ (June 2015). "HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide ... Myeloproliferative neoplasms, including acute leukemia, non-Hodgkin lymphoma and multiple myeloma, occurred in 5 of 119 ... Or-Geva N, Reisner Y (March 2016). "The evolution of T-cell depletion in haploidentical stem-cell transplantation". British ... Robinson TM, O'Donnell PV, Fuchs EJ, Luznik L (April 2016). "Haploidentical bone marrow and stem cell transplantation: ...
Thymidine kinase in clinical chemistry
"Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation". Transplantation Proceedings. 20 (3 ... Lipkin M, Deschner E, Troncale F (1970). "Cell differentiation and the development of colonic neoplasms". CA: A Cancer Journal ... "Biochemical measure of the volume doubling time of human pulmonary neoplasms". Cancer. 55 (7): 1530-5. doi:10.1002/1097-0142( ...
Chemotherapy
Survivors of childhood cancer are more than 13 times as likely to get a secondary neoplasm during the 30 years after treatment ... Léger, Chantal S.; Nevill, Thomas J. (11 May 2004). "Hematopoietic stem cell transplantation: a primer for the primary care ... In chemotherapy as a conditioning regimen in hematopoietic stem cell transplantation, a study of people conditioned with ... The most common secondary neoplasm is secondary acute myeloid leukemia, which develops primarily after treatment with ...
Cell damage
2008). 'Metabolic Management - Organ Procurement and Preservation For Transplantation. New York: Landes Bioscience Springer. ... Carcinogenesis and Neoplasm) and reference). Furthermore, the ability of HRR to accurately and efficiently repair double-strand ...
Markus Büchler
"Expertscape: Pancreatic Neoplasms, November 2018". expertscape.com. November 2018. Retrieved 2018-11-26. Scholia has an author ... "Director of the Clinic for General, Visceral and Transplantation Surgery". Heidelberg surgery hospital. Retrieved 22 March 2012 ... Visceral and Transplantation Surgery at Heidelberg University Hospital. Since 2003 he is managing medical director of the ... Neoplasms of the Pancreas. Karger 2004, ISBN 3-8055-7613-7 Chronic Pancreatitis. Wiley-Blackwell 2002, ISBN 0-632-06399-8 ...
Plasma cell dyscrasias
μ Heavy chain disease presents with a picture of a lymphoid neoplasm resembling either chronic lymphocytic leukemia or small ... or symptomatic disseminated disease have been treated with chemotherapy often followed by autologous stem-cell transplantation ... or other B cell-associated neoplasm, that has developed, often in a stepwise manner, from their MGUS precursors. The clinical ... of patients lack any evidence of a lymphoplasmacytic neoplasm. A majority of the latter patients have an autoimmune disease or ...
Megestrol acetate
Frick J, Marberger H, Swoboda HP (May 1971). "[Hormone therapy of prostatic neoplasms]". Urologe (in German). 10 (3): 117-9. ... A historical overview". Hair Transplantation, Third Edition. Taylor & Francis. pp. 1-33. ISBN 978-0-8247-9363-0. Shamim Tejani ...
Glycogen storage disease type I
Adenomas, composed of heterogeneous neoplasms, may occur individually or in multiples. Estimates on the rate of conversion of a ... Several children with advanced hepatic complications have improved after liver transplantation. Additional problems reported in ...
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm,... | Archive ouverte UNIGE
MCLORNAN, Donal P et al. Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, ... Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective ... Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982). Citation. (ISO format) ... Myeloproliferative Neoplasm (MPN), unclassifiable (MPN-U) is a heterogeneous disease with regards to both clinical phenotype ...
Risk of myeloid neoplasms after solid organ transplantation
Plasma cell neoplasms in U.S. solid organ transplant recipients Cite CITE. Title : Plasma cell neoplasms in U.S. solid organ ... Title : Risk of myeloid neoplasms after solid organ transplantation Personal Author(s) : Morton, Lindsay M.;Gibson, Todd M.; ... SIRs were highest among younger individuals and varied by time since transplantation and organ type (Poisson regression P. ... Title : Risk of lymphoma subtypes after solid organ transplantation in the United States Personal Author(s) : Clarke, C A; ...
Neoplasm Transplantation | Mary Lyon Centre
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. ...
Yellow Fever Vaccine
YF vaccine is contraindicated for persons with primary immunodeficiencies, malignant neoplasms, and transplantation (127). ... malignant neoplasms, 5) transplantation, and 6) immune suppression or modulation attributable to current or recent radiation ... Live viral vaccines should be deferred in persons with a history of malignant neoplasm or transplantation until immune function ... solid organ transplant or hematopoietic stem cell transplant recipients within 2 years of transplantation, or persons whose ...
Pediatric Heart Transplantation: Practice Essentials, Background, Indications
According to the registry of the International Society for Heart and Lung Transplantation, approximately 350-500 pediatric ... heart transplantation procedures are performed worldwide each year, representing about 12% of the total number of heart ... Heart transplantation in infants and children is now accepted therapy. ... By 1984, the medical field was again ready for infant transplantation. For the next 10 years, orthotopic heart transplantation ...
Yellow Fever - Chapter 4 - 2020 Yellow Book | Travelers' Health | CDC
Bone Marrow Disease | Bone Marrow | MedlinePlus
Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable (National Cancer Institute) Also in Spanish * Myelofibrosis (Mayo ... Bone Marrow Transplantation: MedlinePlus Health Topic (National Library of Medicine) Also in Spanish ... Treatment Option Overview (Chronic Myeloproliferative Neoplasms) (National Cancer Institute) Also in Spanish ... Treatment Option Overview (Myelodysplastic/Myeloproliferative Neoplasms) (National Cancer Institute) Also in Spanish ...
按主题浏览
MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1
Primary Cardiac Neoplasms Workup: Laboratory Studies, Imaging Studies, Other Tests
... of all these neoplasms. The remainder of the pathological spectrum includes benign and malignant cell types. ... Treatment of cardiac tumors by orthotopic cardiac transplantation. Semin Oncol. 1997 Oct. 24(5):534-9. [QxMD MEDLINE Link]. ... encoded search term (Primary Cardiac Neoplasms) and Primary Cardiac Neoplasms What to Read Next on Medscape ... Primary Cardiac Neoplasms Workup. Updated: Mar 16, 2023 * Author: Mary C Mancini, MD, PhD, MMM; Chief Editor: Eric H Yang, MD ...
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms - Full Text View - ClinicalTrials.gov
History of haploidentical allogeneic stem cell transplantation. *Subjects both with urinary outflow obstructions and on ... TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms. The safety and scientific validity of this study is ... The Phase I dose escalation part will establish the MTD/RP2D in subjects with high risk myeloid and lymphoid neoplasms, a total ... in Subjects With High Risk Myeloid and Lymphoid Neoplasms. ...
中文
Andrea K. Ng, MD, MPH - Dana-Farber Cancer Institute | Boston, MA
Neoplasm - Wikipedia
"The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation". N. Engl. J. Med. 332 (1 ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... p. Neoplasm. ISBN 978-0781733908. .. *^ "II Neoplasms". International Statistical Classification of Diseases and Related Health ... The term neoplasm is a synonym of tumor. Neoplasia denotes the process of the formation of neoplasms/tumors, and the process is ...
Kai Yang, Ph.D. | Harvard Catalyst Profiles | Harvard Catalyst
IgM monoclonal gammopathies of clinical significance: diagnosis and management
| Haematologica
By contrast, the cases of pure plasma cell neoplasm (23%) had similar rates of t(11;14) compared to non-IgM-associated ... The largest series of autologous stem cell transplantation in 38 patients44 included 58% who had received prior therapy and the ... The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-2390. https ... The best outcomes have been achieved by autologous stem cell transplantation, with more than 90% achieving a hematologic ...
ZFIN Publication: Ghotra et al., 2012
Anatomical Pathology | Hospital de Bellvitge
Editorial Calendar
Daniel J Weisdorf - Projects and Grants
- [email protected]
NK Cells, Their Receptors, Transplantation and Cancer Th. Miller, J. S., Cooley, S. A., Ho, Y., Le, C. T., Luo, X., Tolar, J., ... Enhancing the Safety of Allogeneic Transplantation. Weisdorf, D. J., Arora, M., Brunstein, C. G., McClune, B. L. & Wagner, J. E ... Enhancing the Safety of Allogeneic Transplantation. Weisdorf, D. J., Arora, M., Brunstein, C. G., McClune, B. L. & Wagner, J. E ... Project 2: (Bhatia/Bhatia) Therapy-related leukemia following autologous transplantation for lymphoma. Weisdorf, D. J. & Arora ...
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan...
In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 7, 07.2019, p. 1424-1431.. Research output: Contribution to ... High-dose busulfan (BU) followed by high-dose cyclophosphamide (CY) before allogeneic hematopoietic cell transplantation (HCT) ... N2 - High-dose busulfan (BU) followed by high-dose cyclophosphamide (CY) before allogeneic hematopoietic cell transplantation ( ... AB - High-dose busulfan (BU) followed by high-dose cyclophosphamide (CY) before allogeneic hematopoietic cell transplantation ( ...
Stinne Holm Bergholdt - Research output
- University of Southern Denmark
Do Race and Poverty Increase TKR Failure Risk? No, Study Finds
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in...
... for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications ... Hematologic Neoplasms Hematologic Diseases Severe Aplastic Anemia Pediatric Adult , Myelodysplastic Syndromes (MDS) , A ... Aplastic Anemia, Aplastic Anemia, Anemia; Non-Small-Cell Lung Cancer, Myelodysplastic Syndromes (MDS), Hematologic Neoplasms ... A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in ...
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results...
Central Nervous System Neoplasms / therapy* * Combined Modality Therapy * Disease-Free Survival * Febrile Neutropenia / ... Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results ... or intensive chemotherapy and autologous stem-cell transplantation (ASCT) as a first-line treatment of primary CNS lymphoma ( ...
Budd-Chiari Syndrome Medication: Anticoagulants, Cardiovascular, Antifibrinolytic Agents, Diuretic Agents
Myeloproliferative neoplasms and recurrent thrombotic events in patients undergoing liver transplantation for Budd-Chiari ... Hepatic venous and inferior vena cava morphology no longer a barrier to living donor liver transplantation for Budd-Chiari ... Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007 Sep. 13(9): ... Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl. 2008 Feb. 14( ...
Mohammed Javeed I Ansari - Research Output - Northwestern Scholars
Novel Diagnostics in Transplantation. Ansari, MJ. & Strom, TB., 2010, Chronic Kidney Disease, Dialysis and Transplantation. ... Thorp, E. B., Stehlik, C. & Ansari, M. J., Feb 21 2015, In: Current opinion in organ transplantation. 20, 1, p. 37-42 6 p.. ... Yuan, X., Ansari, M. J. & Sayegh, M. H., Feb 1 2006, In: Current opinion in organ transplantation. 11, 1, p. 24-29 6 p.. ... Abadja, F., Sarraj, B. & Ansari, M. J., Feb 2012, In: Current opinion in organ transplantation. 17, 1, p. 8-14 7 p.. Research ...
Mayor Erythropoietic Response after Deferasirox Treatment in a Transfusion-Dependent Anemic Patient with Primary Myelofibrosis
... is a myeloproliferative neoplasm frequently complicated by transfusion dependent anemia. Both anemia and transfusion-dependence ... With the exception of few cases eligible to bone marrow transplantation, no known treatment is able to alter the natural course ... Primary myelofibrosis (PMF) is a myeloproliferative neoplasm frequently complicated by transfusion dependent anemia. Both ... PMF is a myeloproliferative neoplasm frequently complicated by transfusion-dependent anemia. ...
Research Articles | Page 91 | Aplastic Anemia & MDS International Foundation
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) A Case Series of Post-Transplantation Cyclophosphamide in ... Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation aplastic ... myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable ... Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia Jun 2020 ...
Organ transplantationMyeloproliferative NeoplasmStem cell transplantLymphomaBlood and Marrow TransplantationBlastic plasmacytoid dendritic celUnclassifiableOutcomesHematopoietic cell2022RenalCell TransplantationLymphoid neoplasmsMetastatic neoplasmsRadiotherapyHepaticChemotherapyBone marrowMPNsOrthotopicTumorPatientsLiverTumorsChronicKidneyLung TransplantationComplicationsCancersCancerBenignPrimaryCarcinomaSurgical
Organ transplantation2
- Current opinion in organ transplantation. (northwestern.edu)
- I worked for 15 year for two global medical associations, the International Society of Nephrology (ISN) and the European Society for Organ Transplantation (ESOT). (segantini.blog)
Myeloproliferative Neoplasm5
- Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. (unige.ch)
- Myeloproliferative Neoplasm (MPN), unclassifiable (MPN-U) is a heterogeneous disease with regards to both clinical phenotype and disease course. (unige.ch)
- Primary myelofibrosis (PMF) is a myeloproliferative neoplasm frequently complicated by transfusion dependent anemia. (hindawi.com)
- Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a 'Catch-All' Term? (aamds.org)
- Splenomegaly or hepatosplenomegaly may indicate an overlapping myeloproliferative neoplasm. (cancer.gov)
Stem cell transplant9
- To determine the efficacy and toxicity of chemoimmunotherapy followed by either whole-brain radiotherapy (WBRT) or intensive chemotherapy and autologous stem-cell transplantation (ASCT) as a first-line treatment of primary CNS lymphoma (PCNSL). (nih.gov)
- Allogenic haematopoietic stem cell transplantation (allo-HSCT) is currently not considered. (medicaljournals.se)
- High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends. (elsevier.com)
- High-dose chemotherapy with hematopoietic stem-cell transplantation (HDC/HSCT) has been extensively studied as a potential treatment for breast cancer. (elsevier.com)
- Dive into the research topics of 'High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends. (elsevier.com)
- To date, allogenic stem cell transplantation remains the only curative option for MPNs but it is often not considered due to age-related co-morbidities and high transplant-associated mortality rates. (biomedcentral.com)
- Background: Haematopoietic stem cell transplantation constitutes a therapeutic choice for the treatment of a number of paediatric diseases. (hjn.gr)
- Marta Sobas of Medical University of Wroclaw, Poland: "The decision to perform stem cell transplantation in AML patients who achieved the first complete remission is based on the risk-benefit ratio. (harmony-alliance.eu)
- Patients with a low to intermediate risk of relapse are not classical candidates for stem cell transplantation. (harmony-alliance.eu)
Lymphoma5
- For lymphoid neoplasms, e.g. lymphoma and leukemia , clonality is proven by the amplification of a single rearrangement of their immunoglobulin gene (for B cell lesions) or T cell receptor gene (for T cell lesions). (wikipedia.org)
- 1 IgM MGUS is a pre-malignant condition for non-Hodgkin lymphomas, mostly Waldenström macroglobulinemia (WM), chronic lymphocytic lymphoma, and plasma cell neoplasms. (haematologica.org)
- We conclude that malignant tumors occurring after transplantation are often advanced and that lymphoma induced by cyclosporine has characteristic features. (elsevier.com)
- Dr. Nishihori's clinical interests include autologous and allogeneic hematopoietic cell transplantation as well as immunotherapeutic approaches for multiple myeloma, plasma cell dyscrasias, amyloidosis, malignant lymphoma, acute and chronic leukemias, myelodysplastic syndrome, myelofibrosis and myeloproliferative disorders. (moffitt.org)
- Lymphoma is a malignant neoplasm that develops in the lymph nodes. (bvsalud.org)
Blood and Marrow Transplantation2
- Biology of Blood and Marrow Transplantation , 25 (7), 1424-1431. (elsevier.com)
- Dr. Nishihori is an assistant member in the Blood and Marrow Transplantation Department at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida. (moffitt.org)
Blastic plasmacytoid dendritic cel2
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is primarly a disease of the elderlies with an overall infaust prognosis. (medicaljournals.se)
- Based on the clinico-pathological correlation the diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) was retained. (medicaljournals.se)
Unclassifiable1
- 2) to establish a possible relationship between clinical and laboratory findings in the context of Polycythemia Vera (PV), Essential Thrombocytemia (ET), Primary Myelophibrosis (PMF) and Myeloproliferative Neoplasms unclassifiable (MPN-U). (scirp.org)
Outcomes4
- Treatment strategies are variable and there are no widely accepted consensus management guidelines for MNU-U. Allogeneic Haematopoietic Cell Transplantation (allo-HCT) remains the only curative strategy yet outcomes, to date, are not well defined. (unige.ch)
- This review introduces various methods and strategies to improve ovarian tissue cryopreservation and transplantation outcomes, to help patients and clinicians choose the best option when considering the potential complexity of a patient's situation. (dundee.ac.uk)
- Currently, chemotherapy and liver transplantation have improved outcomes. (bvsalud.org)
- Abdel-Rahman O , Ghosh S , Morrish D . Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms. (wjgnet.com)
Hematopoietic cell2
- High-dose busulfan (BU) followed by high-dose cyclophosphamide (CY) before allogeneic hematopoietic cell transplantation (HCT) has long been used as treatment for hematologic malignancies. (elsevier.com)
- List the important advances in pretransplantation risk assessment and transplant techniques for hematopoietic cell transplantation in patients with myeloid malignancies. (clevelandclinicmeded.com)
20221
- Dr. Zeeshan Ansar participated in a virtual activity on, ' The 1st Congress on Myeloproliferative Neoplasms controversies and debates ', European board for accreditation in Haematology- EBAH, November 11-12, 2022. (aku.edu)
Renal4
- Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. (cdc.gov)
- INTRODUCTION: The NRF is the organization fnancing in Uruguay the treatment of the three renal replacement techniques (RRT): kidney transplantation (TxR), peritoneal dialysis (PD) and hemodialysis (HD). (bvsalud.org)
- Tumor diameter on cross sectional imaging remains the key parameter for treatment de cisions in renal neoplasms, with nephrectomy being preferred for larger lesions. (sjkdt.org)
- Introduction: Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) and is associated with decreased mortality when compared to dialysis methods. (unifesp.br)
Cell Transplantation1
- Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction - MiHeart/AMI study. (ebsco.com)
Lymphoid neoplasms1
- The Phase I dose escalation part will establish the MTD/RP2D in subjects with high risk myeloid and lymphoid neoplasms, a total of 3 disease entities. (clinicaltrials.gov)
Metastatic neoplasms2
- Secondary or metastatic neoplasms arise from hematologic spread of the originating tissue. (medscape.com)
- The role of electron microscopy in characterization of uncommon epithelial pulmonary neoplasms, metastatic neoplasms to and from lung and other tumors, including mesenchymal neoplasms. (uab.edu)
Radiotherapy1
- Secondary neoplasm refers to any of a class of cancerous tumor that is either a metastatic offshoot of a primary tumor, or an apparently unrelated tumor that increases in frequency following certain cancer treatments such as chemotherapy or radiotherapy . (wikipedia.org)
Hepatic3
- Spectral Doppler ultrasonographic waveform of the right hepatic artery in a 60-year-old man, 8 years after orthotopic liver transplantation. (medscape.com)
- A-1: Magnetic resonance angiogram in a transplantation patient with hepatic artery thrombosis. (medscape.com)
- Methodology: a retrospective survey of medical records of patients aged up to 18 years with a diagnosis of primary malignant hepatic neoplasm between 2012 and 2020, carried out in the largest exclusively pediatric hospital in Brazil. (bvsalud.org)
Chemotherapy1
- However, the results and survival have improved with the advancement of chemotherapy, surgical technique, and liver transplantation. (bvsalud.org)
Bone marrow2
- Bone marrow transplantation. (bvsalud.org)
- Ciclosporin, an immunosuppressant, is used extensively in the prevention and treatment of graft-versus-host reactions in bone-marrow transplantation and to prevent the rejection of kidney, heart, and liver transplants. (who.int)
MPNs3
- Histopathology, the standard method to assess BM in hematologic malignancies such as myeloproliferative neoplasms (MPNs), suffers from notable limitations in both research and clinical settings. (jci.org)
- Myeloproliferative neoplasms (MPNs) are a group of chronic clonal haematopoietic disorders. (biomedcentral.com)
- High-throughput DNA sequence analysis was used to screen for TET2 mutations in peripheral blood derived DNA from 97 patients with BCR-ABL-negative-myeloproliferative neoplasms (MPNs). (scirp.org)
Orthotopic5
- [ 3 ] . An increasing number of orthotopic and living-donor liver transplantations are being performed to salvage patients with otherwise incurable end-stage liver disease (ESLD). (medscape.com)
- Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. (edu.au)
- OBJECTIVE: To establish a series of clinically relevant orthotopic transplantation models of human pancreatic adenocarcinoma from both cell lines and primary tumors under uniform experimental conditions. (edu.au)
- Dive into the research topics of 'Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. (edu.au)
- The armamentarium for managing HCC is wide and includes surgical resection, orthotopic liver transplantation (OLT), ablative techniques using ethanol (percutaneous ethanol injection, PEI), microwave (MWA) or radiofrequency (RFA), catheter-directed transarterial chemoembolization (TACE) or radioembolization (TARE), external beam radiation therapy in the form of stereotactic body radiation therapy (SBRT) or proton beam therapy (PBT), systemic targeted small molecule tyrosine kinase inhibitors, check-point inhibitor immunotherapy and investigational agents. (intechopen.com)
Tumor5
- In modern English, tumor is used as a synonym for neoplasm (a solid or fluid-filled cystic lesion that may or may not be formed by an abnormal growth of neoplastic cells) that appears enlarged in size. (wikipedia.org)
- [12] [13] Some neoplasms do not form a tumor - these include leukemia and most forms of carcinoma in situ . (wikipedia.org)
- El Sarcoma Embrionario Indiferenciado, como tumor primario hepático es una patología que se presenta en la edad pediátrica, en adultos los casos son raros y representan aproximadamente el 0.2% de los tumores hepáticos primarios. (bvsalud.org)
- El tratamiento curativo consiste en la resección quirúrgica del tumor y, en casos de irresecabilidad o afectación extrahepática, se justifica considerar radioquimioterapia paliativa y asociarla o no a cirugía. (bvsalud.org)
- Heart transplantation may be appropriate in those instances in which the benign tumor is too large to resect. (medscape.com)
Patients3
- Lee et al retrospectively enrolled 75 patients who had undergone liver transpalantation and found that although MDCT in the late period should be interpreted with caution in patients with suspected biliary complication, MDCT is a reliable diagnostic technique for the identification of early and late abdominal complications after liver transplantation. (medscape.com)
- Ovarian tissue cryopreservation and transplantation is a promising option for fertility preservation in pre-pubertal girls and adult patients with cancer who require immediate treatment, or who are not eligible to undergo ovarian stimulation. (dundee.ac.uk)
- Skin cancer is the most frequently described neoplasm among OTRs, whereas squamous cell carcinoma (SCC) is very often declared to be the most frequently occurring cancer among those patients. (termedia.pl)
Liver5
- [ 4 ] Doppler ultrasonography plays an important role in the postoperative management of liver transplantation. (medscape.com)
- ABSTRACT Introduction: liver tumors are rare neoplasms in childhood (1-2%), and about 2/3 are malignant. (bvsalud.org)
- Only one patient was treated with surgery without neoadjuvant therapy, another one underwent transplantation like the first treatment, and another 2 required liver transplantation as a rescue. (bvsalud.org)
- He is accredited by the American Society of Transplant Surgeons and Ministry of Health in liver, kidney and pancreas transplantation. (annals.edu.sg)
- He is a thought leader in the field for his clinical and academic work on laparoscopic and robotic surgery, liver cancers and pancreatic cystic neoplasms. (annals.edu.sg)
Tumors2
- The neoplasms of the skin, vulva, uterine cervix, and urinary bladder were low-grade malignant tumors. (elsevier.com)
- Although the overall incidence of primary cardiac neoplasms is low (0.0001-0.5% in autopsy series), these tumors provide unique diagnostic and therapeutic challenges. (medscape.com)
Chronic1
- My scientific focus is leukemia, specifically myeloproliferative neoplasms (MPN) including CML, chronic myelomonocytic leukemia (CMML) and myelofibrosis (MF). (utah.edu)
Kidney1
- Cystic nephroma (CN) is a rare benign neoplasm of kidney with excellent prog nosis. (sjkdt.org)
Lung Transplantation1
- Journal of Heart and Lung Transplantation. (northwestern.edu)
Complications2
- See the images below of transplantation complications. (medscape.com)
- This Philadelphia negative-myeloproliferative neoplasms (MPN) are a spectrum of clonal disorders of the hematopoietic system characterized by overproduction of mature blood elements, a trend to thrombotic and/or hemorrhagic complications with variable rates of transformation to secondary myelofibrosis and acute leukemia [1]. (scirp.org)
Cancers1
- [7] Malignant neoplasms are also simply known as cancers and are the focus of oncology . (wikipedia.org)
Cancer6
- A neoplasm can be benign , potentially malignant, or malignant ( cancer ). (wikipedia.org)
- Malignant neoplasms are commonly called cancer. (wikipedia.org)
- Rarely there can be a metastatic neoplasm with no known site of the primary cancer and this is classed as a cancer of unknown primary origin . (wikipedia.org)
- Effective multidisciplinary oncofertility strategies, involving the inclusion of a highly skilled and experienced oncofertility team that considers cryopreservation methods, thawing processes and devices, surgical procedures for transplantation, and advances in technologies, are necessary to provide high-quality care to a cancer patient. (dundee.ac.uk)
- His thesis from 1938 was on transplantation of cancer from one animal species to another after Xray exposure. (who.int)
- His publication series in 5 volumes "Statistical studies in malignant neoplasms" still stand as a milestone in cancer epidemiology with observations and analysis and literature review up to 1977. (who.int)
Benign1
- benign neoplasms , in situ neoplasms , malignant neoplasms , and neoplasms of uncertain or unknown behavior. (wikipedia.org)
Primary2
- The primary objective of this study is to examine the incidence of neutrophil recovery of greater than or equal to 500/mm(3) after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed. (centerwatch.com)
- Primary neoplasms may arise from endocardium, valvular structures, primitive tissue rests, and the conduction system. (medscape.com)
Carcinoma1
- Potentially-malignant neoplasms include carcinoma in situ . (wikipedia.org)
Surgical1
- This closed cryopreservation/defrost system allows for sterility in addition to increased viability, recovery and safety of tissues that can be used for in vitro culture or surgical transplantation. (cancer.gov)